Skip to main content
Clinical Trials/CTRI/2023/12/060625
CTRI/2023/12/060625Not yet recruitingUnknown

To Study the role of immature platelet fraction in childrenwith severe thrombocytopenia - NI

MANIPAL ACADEMY OF HIGHER EDUCATIO0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Cases: Children from 1month to 18years of age with severe thrombocytopenia
  • having Platelet count less than 1,00,000 per microlitre.
  • Control: Controls: Children from 1month to 18years of age with platelet
  • counts within normal limits 1,50,000/microlitre to 4,50,000/microlitre

Exclusion Criteria

  • Children diagnosed with haematological malignancies (leukaemia, lymphoma)
  • and currently on anti-cancer drugs.
  • Children previously diagnosed of idiopathic thrombocytopenic purpura,
  • thrombotic thrombocytopenic purpura, aplastic anemia on disease specific
  • Children who had received platelet transfusion in the past 1 month

Investigators

Sponsor
MANIPAL ACADEMY OF HIGHER EDUCATIO

Similar Trials

Immature platelet fraction in children... | Clinical Trial